MESO Q1 2026 Earnings Slightly Wider Loss in PreRevenue Quarter Stock Advances Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Focuses on Pipeline Progress Corteva Q1 2026 Earnings Earnings Beat Estimates by 25 on Strong Operational Performance Quince Therapeutics Inc QNCX Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by Over 200 MLYS Q1 2026 Earnings Narrowerthanexpected loss as clinicalstage company advances pipeline Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress